{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:24:22Z","timestamp":1777983862491,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Lliga contra el C\u00e0ncer, Comarques de Tarragona i Terres de l\u2019Ebre","award":["Ref PR-010-2022"],"award-info":[{"award-number":["Ref PR-010-2022"]}]},{"name":"Lliga contra el C\u00e0ncer, Comarques de Tarragona i Terres de l\u2019Ebre","award":["Ref PR-010-2022"],"award-info":[{"award-number":["Ref PR-010-2022"]}]},{"name":"Lliga contra el C\u00e0ncer, Comarques de Tarragona i Terres de l\u2019Ebre","award":["Ref PR-010-2022"],"award-info":[{"award-number":["Ref PR-010-2022"]}]},{"name":"Lliga contra el C\u00e0ncer, Comarques de Tarragona i Terres de l\u2019Ebre","award":["Ref PR-010-2022"],"award-info":[{"award-number":["Ref PR-010-2022"]}]},{"name":"Lliga contra el C\u00e0ncer, Comarques de Tarragona i Terres de l\u2019Ebre","award":["Ref PR-010-2022"],"award-info":[{"award-number":["Ref PR-010-2022"]}]},{"name":"Lliga contra el C\u00e0ncer, Comarques de Tarragona i Terres de l\u2019Ebre","award":["Ref PR-010-2022"],"award-info":[{"award-number":["Ref PR-010-2022"]}]},{"name":"Lliga contra el C\u00e0ncer, Comarques de Tarragona i Terres de l\u2019Ebre","award":["Ref PR-010-2022"],"award-info":[{"award-number":["Ref PR-010-2022"]}]},{"name":"Lliga contra el C\u00e0ncer, Comarques de Tarragona i Terres de l\u2019Ebre","award":["Ref PR-010-2022"],"award-info":[{"award-number":["Ref PR-010-2022"]}]},{"name":"Lliga contra el C\u00e0ncer, Comarques de Tarragona i Terres de l\u2019Ebre","award":["Ref PR-010-2022"],"award-info":[{"award-number":["Ref PR-010-2022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35789-8","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T19:04:24Z","timestamp":1769886264000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolomic-driven prediction of the mutational status of healthy individuals with a family history of hereditary breast and ovarian cancer syndrome: the HRRmet study"],"prefix":"10.1038","volume":"16","author":[{"given":"B\u00e0rbara","family":"Roig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Fern\u00e1ndez-Castillejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Gum\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Badia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Mel\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f2nica","family":"Salvat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Querol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Cumeras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Rodr\u00edguez-Balada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"35789_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/362709a0","volume":"362","author":"T Lindahl","year":"1993","unstructured":"Lindahl, T. Instability and decay of the primary structure of DNA. Nature 362, 709\u2013715 (1993).","journal-title":"Nature"},{"key":"35789_CR2","doi-asserted-by":"crossref","unstructured":"Toss, A. et al. Hereditary ovarian cancer: Not only BRCA 1 and 2 Genes. Biomed Res. Int. (2015).","DOI":"10.1155\/2015\/341723"},{"key":"35789_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10689-016-9883-7","volume":"15","author":"G Goyal","year":"2016","unstructured":"Goyal, G., Fan, T. & Silberstein, P. T. Hereditary cancer syndromes: utilizing DNA repair deficiency as therapeutic target. Fam Cancer. 15, 359\u2013366 (2016).","journal-title":"Fam Cancer"},{"key":"35789_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nrc.2015.21","volume":"16","author":"CJ Lord","year":"2016","unstructured":"Lord, C. J. & Ashworth, A. BRCAness revisited. Nat. Rev. Cancer. 16, 110\u2013120 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"35789_CR5","unstructured":"Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica (SEOM). C\u00e1ncer de Mama y Ovario Hereditario.  https:\/\/seom.org\/informacion-sobre-el-cancer\/consejo-genetico?start=4 (2021)."},{"key":"35789_CR6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/jmedgenet-2015-103570","volume":"53","author":"JD Fackenthal","year":"2016","unstructured":"Fackenthal, J. D. et al. Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples. J. Med. Genet. 53, 548\u2013558 (2016).","journal-title":"J. Med. Genet."},{"key":"35789_CR7","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker, K. B. et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA - J. Am. Med. Assoc. 317, 2402\u20132416 (2017).","journal-title":"JAMA - J. Am. Med. Assoc."},{"key":"35789_CR8","unstructured":"D\u00edez, O. S\u00edndromes hereditarios en oncolog\u00eda. Hosp. la St. Creu i St. Pau. Barcelona Divers. III, 664 (2016)."},{"key":"35789_CR9","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.jmig.2020.11.023","volume":"28","author":"E Matanes","year":"2021","unstructured":"Matanes, E. et al. Endometrial cancer in germline BRCA mutation carriers: A systematic review and Meta-analysis. J. Minim. Invasive Gynecol. 28, 947\u2013956 (2021).","journal-title":"J. Minim. Invasive Gynecol."},{"key":"35789_CR10","unstructured":"LOVD. LOVD Variants Database. https:\/\/www.lovd.nl\/"},{"key":"35789_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66\u201371 (1994).","journal-title":"Science"},{"key":"35789_CR12","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster, R. et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789\u2013792 (1995).","journal-title":"Nature"},{"key":"35789_CR13","unstructured":"National Human Genome Research Institute. Breast cancer information core. https:\/\/research.nhgri.nih.gov\/bic\/"},{"key":"35789_CR14","doi-asserted-by":"crossref","unstructured":"Kaur, R., Gupta, S., Kulshrestha, S., Khandelwal, V. & Pandey, S. Metabolomics-driven biomarker discovery for breast cancer prognosis and metabolomics-driven biomarker discovery for breast cancer prognosis and diagnosis. Cells 14, (2025).","DOI":"10.3390\/cells14010005"},{"key":"35789_CR15","doi-asserted-by":"publisher","unstructured":"Johnson, C. H., Ivanisevic, J., Siuzdak, G. & Metabolomics beyond biomarkers and towards mechanisms. Nat. Rev. Mol. Cell Biol. 17 451\u2013459  https:\/\/doi.org\/10.1038\/nrm.2016.25 (2016).","DOI":"10.1038\/nrm.2016.25"},{"key":"35789_CR16","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1021\/pr500443c","volume":"13","author":"Y Ni","year":"2014","unstructured":"Ni, Y., Xie, G. & Jia, W. Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J. Proteome Res. 13, 3857\u20133870 (2014).","journal-title":"J. Proteome Res."},{"key":"35789_CR17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/nbm.1478","volume":"23","author":"B Sitter","year":"2010","unstructured":"Sitter, B. et al. Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR Biomed. 23, 424\u2013431 (2010).","journal-title":"NMR Biomed."},{"key":"35789_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0076220","volume":"8","author":"PG Shaw","year":"2013","unstructured":"Shaw, P. G. et al. Integrated proteomic and metabolic analysis of breast cancer progression. PLoS One. 8, 1\u201312 (2013).","journal-title":"PLoS One"},{"key":"35789_CR19","doi-asserted-by":"publisher","first-page":"5065","DOI":"10.1007\/s00216-015-8484-x","volume":"407","author":"L Yang","year":"2015","unstructured":"Yang, L. et al. Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers. Anal. Bioanal Chem. 407, 5065\u20135077 (2015).","journal-title":"Anal. Bioanal Chem."},{"key":"35789_CR20","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.1158\/0008-5472.CAN-10-1319","volume":"70","author":"VM Asiago","year":"2010","unstructured":"Asiago, V. M. et al. Early detection of recurrent breast cancer using metabolite profiling. Cancer Res. 70, 8309\u20138318 (2010).","journal-title":"Cancer Res."},{"key":"35789_CR21","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1593\/tlo.13619","volume":"6","author":"J Shen","year":"2013","unstructured":"Shen, J., Yan, L., Liu, S., Ambrosone, C. B. & Zhao, H. Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes. Transl Oncol. 6, 757\u2013765 (2013).","journal-title":"Transl Oncol."},{"key":"35789_CR22","doi-asserted-by":"publisher","first-page":"17831","DOI":"10.1038\/s41598-017-17897-8","volume":"7","author":"B Roig","year":"2017","unstructured":"Roig, B. et al. Metabolomics reveals novel blood plasma biomarkers associated to the BRCA1-mutated phenotype of human breast cancer. Sci. Rep. 7, 17831 (2017).","journal-title":"Sci. Rep."},{"key":"35789_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13058-024-01896-5","volume":"26","author":"HC Wu","year":"2024","unstructured":"Wu, H. C. et al. Plasma metabolomics profiles and breast cancer risk. Breast Cancer Res. 26, 141 (2024).","journal-title":"Breast Cancer Res."},{"key":"35789_CR24","doi-asserted-by":"crossref","unstructured":"Neagu, A. N. et al. Omics-based investigations breast cancer molecules 28, (2023).","DOI":"10.3390\/molecules28124768"},{"key":"35789_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2023.1292046","volume":"13","author":"L Alvarez-Frutos","year":"2023","unstructured":"Alvarez-Frutos, L. et al. Multiomics insights on the onset, progression, and metastatic evolution of breast cancer. Front. Oncol. 13, 1\u201319 (2023).","journal-title":"Front. Oncol."},{"key":"35789_CR26","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41591-019-0404-8","volume":"25","author":"H Li","year":"2019","unstructured":"Li, H. et al. The landscape of cancer cell line metabolism. Nat. Med. 25, 850\u2013860 (2019).","journal-title":"Nat. Med."},{"key":"35789_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2021.722656","volume":"12","author":"J M\u00e4rz","year":"2021","unstructured":"M\u00e4rz, J. et al. Plasma metabolome profiling for the diagnosis of catecholamine producing tumors. Front. Endocrinol. (Lausanne). 12, 1\u201311 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"35789_CR28","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1158\/1055-9965.EPI-21-0457","volume":"9","author":"DA Drew","year":"2021","unstructured":"Drew, D. A. Metabolomics as a tool for biomarker discovery in gastric cancer. Cancer Epidemiol. Biomarkers Prev. 9, 1601\u20131603 (2021).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"35789_CR29","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1158\/1055-9965.EPI-18-0079","volume":"28","author":"CD Adams","year":"2019","unstructured":"Adams, C. D. et al. Circulating metabolic biomarkers of screen-detected prostate cancer in the protect study. Cancer Epidemiol. Biomarkers Prev. 28, 208\u2013216 (2019).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"35789_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/emmm.201911217","volume":"12","author":"\u00c1 Lahiguera","year":"2020","unstructured":"Lahiguera, \u00c1. et al. Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors. EMBO Mol. Med. 12, 1\u201323 (2020).","journal-title":"EMBO Mol. Med."},{"key":"35789_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s12020-021-02858-z","volume":"75","author":"NG Bliziotis","year":"2022","unstructured":"Bliziotis, N. G. et al. Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paraganglioma. Endocrine 75, 254\u2013265 (2022).","journal-title":"Endocrine"},{"key":"35789_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1079\/PHN2002430","volume":"6","author":"GK Davey","year":"2003","unstructured":"Davey, G. K. et al. EPIC\u2013Oxford:lifestyle characteristics and nutrient intakes in a cohort of 33 883 meat-eaters and 31 546 Non meat-eaters in the UK. Public. Health Nutr. 6, 259\u2013268 (2003).","journal-title":"Public. Health Nutr."},{"key":"35789_CR33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"35789_CR34","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10863-024-10028-9","volume":"56","author":"M Takai","year":"2024","unstructured":"Takai, M., Mori, S., Honoki, K. & Tsujiuchi, T. Roles of lysophosphatidic acid (LPA) receptor-mediated signaling in cancer cell biology. J. Bioenerg Biomembr. 56, 475\u2013482 (2024).","journal-title":"J. Bioenerg Biomembr."},{"key":"35789_CR35","doi-asserted-by":"crossref","unstructured":"Subramani, R., Poudel, S., Smith, K. D., Estrada, A. & Lakshmanaswamy, R. Metab. Breast Cancer Rev. Metab. 12, (2022).","DOI":"10.3390\/metabo12070643"},{"key":"35789_CR36","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","volume":"1863","author":"N Longo","year":"2016","unstructured":"Longo, N., Frigeni, M. & Pasquali, M. Carnitine transport and fatty acid oxidation. Biochim. Biophys. Acta - Mol. Cell. Res. 1863, 2422\u20132435 (2016).","journal-title":"Biochim. Biophys. Acta - Mol. Cell. Res."},{"key":"35789_CR37","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3390\/cancers17030532","volume":"17","author":"S Fern\u00e1ndez-Castillejo","year":"2025","unstructured":"Fern\u00e1ndez-Castillejo, S. et al. Article ketone bodies are potential prognostic biomarkers in Relapsed\/ refractory diffuse large B-Cell lymphoma: results from the R2-GDP-GOTEL trial. Cancers (Basel). 17, 532 (2025).","journal-title":"Cancers (Basel)"},{"key":"35789_CR38","doi-asserted-by":"crossref","unstructured":"Privat, M. et al. BRCA1 induces major energetic metabolism reprogramming in breast cancer cells. PLoS One 9, (2014).","DOI":"10.1371\/journal.pone.0102438"},{"key":"35789_CR39","doi-asserted-by":"crossref","unstructured":"Chen, J., Cui, L., Lu, S. & Xu, S. Amino acid metabolism in tumor biology and therapy. Cell Death Dis. 15, (2024).","DOI":"10.1038\/s41419-024-06435-w"},{"key":"35789_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2021.627217","volume":"11","author":"J Penkert","year":"2021","unstructured":"Penkert, J. et al. Plasma metabolome signature indicative of BRCA1 germline status independent of cancer incidence. Front. Oncol. 11, 1 (2021).","journal-title":"Front. Oncol."},{"key":"35789_CR41","unstructured":"Servei Catal\u00e0 de la Salut. Determinacions del perfil gen\u00e8tic de les s\u00edndromes heredit\u00e0ries de c\u00e0ncer en l\u2019adult i pediatria. https:\/\/catsalut.gencat.cat\/web\/.content\/minisite\/catsalut\/proveidors_professionals\/documentacio-professionals\/oncologia-precisio-panel-germinals.pdf (2021)."},{"key":"35789_CR42","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/humu.20880","volume":"29","author":"SE Plon","year":"2021","unstructured":"Plon, S. E. et al. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum. Mutat. 29, 1282\u20131291 (2021).","journal-title":"Hum. Mutat."},{"key":"35789_CR43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"35789_CR44","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.ajhg.2024.07.013","volume":"111","author":"MT Parsons","year":"2024","unstructured":"Parsons, M. T. et al. Evidence-based recommendations for gene-specific ACMG\/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 variant curation expert panel. Am. J. Hum. Genet. 111, 2044\u20132058 (2024).","journal-title":"Am. J. Hum. Genet."},{"key":"35789_CR45","doi-asserted-by":"crossref","unstructured":"Richardson, M. E. et al. Specifications of the ACMG \/ AMP variant curation guidelines for the analysis of germline ATM sequence variants authors ARTICLE specifications of the ACMG \/ AMP variant curation guidelines for the analysis of germline ATM sequence variants. Am J. Hum. Genet 111, 2411\u20132426 .","DOI":"10.1016\/j.ajhg.2024.08.022"},{"key":"35789_CR46","first-page":"372","volume":"23","author":"HL Rehm","year":"2015","unstructured":"Rehm, H. L. et al. ClinGen-The Clin. Genome Resource N engl. j. med. 23 372 (2015).","journal-title":"ClinGen-The Clin. Genome Resource N engl. j. med."},{"key":"35789_CR47","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis, N. M. et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am. J. Hum. Genet. 99, 877\u2013885 (2016).","journal-title":"Am. J. Hum. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35789-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35789-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35789-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:03:58Z","timestamp":1771459438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35789-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35789"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35789-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7297956\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6844"}}